Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Kim, Jihyun ^a   Lee, Da Young ^a   Park, Se Eun ^a   Park, Cheol Young ^a   Lee, Won Young ^a   Oh, Ki Won ^a   Park, Sung Woo ^a   Rhee, Eun Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATTENUATION; BODY MASS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CORONARY RISK; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; ATHEROSCLEROSIS; BLOOD; BLOOD VESSEL CALCIFICATION; COMPLICATION; CORONARY BLOOD VESSEL; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

ADULT; ATHEROSCLEROSIS; BODY MASS INDEX; C-REACTIVE PROTEIN; CORONARY VESSELS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 85021856493     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0180118     Document Type: Article

References (32)

1. Browning JD1, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395. https://doi.org/10.1002/hep.20466 PMID: 15565570
2. Younossi ZM, Diehl AM, Ong JP (2002) Non alcoholic fatty liver disease: an agenda for clinical research. Hepatology 35:746–752. https://doi.org/10.1053/jhep.2002.32483 PMID: 11915019
3. Yoon HJ, Cha BS (2014) Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol 6:800–811. https://doi.org/10.4254/wjh.v6.i11.800 PMID: 25429318
4. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. (2006) Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 21(1 Pt 1):138–143.
5. Cho HC (2016) Prevalence and Factors associated with Nonalcoholic Fatty Liver Disease in a Nonob-ese Korean Population. Gut Liver 10:117–125. https://doi.org/10.5009/gnl14444 PMID: 26260755
6. Fargion S, Porzio M, Fracanzani AL (2014) Nonalcoholic fatty liver disease and vascular disease: State-of-the-art. World J Gastroenterology 20:13306–13324.
7. Povero D, Feldstein AE (2016) Novel Molecular Mechanisms in the Development of Non-Alcoholic stea-tohepatitis. Diabetes Metab J 40:1–11. https://doi.org/10.4093/dmj.2016.40.1.1 PMID: 26912150
8. Hajer GR, van Haeften TW, Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29:2959–2971. https://doi.org/10.1093/eurheartj/ehn387 PMID: 18775919
9. Kolak M1, Westerbacka J, Velagapudi VR, Wågsäter D, Yetukuri L, Makkonen J, et al. (2007) Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56:1960–1968. https://doi.org/10.2337/db07-0111 PMID: 17620421
10. Hecht HS (2015) Coronary artery calcium scanning: past, present, and future. JACC Cardiovasc Imaging 8:579–596. https://doi.org/10.1016/j.jcmg.2015.02.006 PMID: 25937196
11. Blankstein R, Gupta A, Rana JS, Nasir K (2017) The Implication of Coronary Artery Calcium Testing for Cardiovascular Disease Prevention and Diabetes. Endocrinol Metab (Seoul) 32:47–57.
12. VanWagner LB, Ning H, Lewis CE, Shay CM, Wilkins J, Carr JJ, et al. (2014) Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study. Atherosclerosis 235:599–605. https://doi.org/10.1016/j.atherosclerosis.2014.05.962 PMID: 24956534
13. Al Rifai M, Silverman MG, Nasir K, Budoff MJ, Blankstein R, Szklo M, et al. (2015) The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 239:629–633. https://doi.org/10.1016/j.atherosclerosis.2015.02.011 PMID: 25683387
14. Chen CH, Nien CK, Yang CC, Yeh YH (2010) Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification. Dig Dis Sci 55:1752–1760. https://doi.org/10.1007/s10620-009-0935-9 PMID: 19688595
15. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212–1218. https://doi.org/10.2337/dc06-2247 PMID: 17277038
16. Park HE, Kwak MS, Kim D, Kim MK, Cha MJ, Choi SY (2016) Nonalcoholic Fatty Liver Disease is Associated with Coronary Artery Calcification Development: A longitudinal study. J Clin Endocrinol Metab 2016; 101:3134–3143. https://doi.org/10.1210/jc.2016-1525 PMID: 27253666
17. McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, et al.(2008) Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 103: 3029–3035. https://doi.org/10.1111/j.1572-0241.2008.02188.x PMID: 18853970
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419. PMID: 3899825
19. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al. (2005) Prevalence ofno-n-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 22:1141-1145. https://doi.org/10.1111/j.1464-5491.2005.01582.x PMID: 16108839
20. Quinn SF, Gosink BB (1985) Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 145:753-755. https://doi.org/10.2214/ajr.145.4.753 PMID: 3898784
21. Rumberger JA, Brundage BH, Rader DJ, Kondos G (1999) Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 74: 243–252. https://doi.org/10.4065/74.3.243 PMID: 10089993
22. Lee JI, Kim MC, Moon BS, Song YS, Han EN, Lee HS, et al. (2016) The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease. Endocrinol Metab (Seoul) 31:86–92.
23. Lee MK, Park HJ, Jeon WS, Park SE, Park CY, Lee WY, et al. (2015) Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study.CardiovascDiabetol 14:88.
24. Byrne CD, Targher G (2014) Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol 34:1155–1161. https://doi.org/10.1161/ATVBAHA.114.303034 PMID: 24743428
25. Sinn DH, Kang D, Chang Y, Ryu S, Gu S, Kim H, et al. (2017) Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. Gut 66:323–329. https://doi.org/10.1136/gutjnl-2016-311854 PMID: 27599521
26. VanWagner LB, Ning H, Lewis CE, Shay CM, Wilkins J, Carr JJ, et al. (2014) Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study. Atherosclerosis 235:599–605. https://doi.org/10.1016/j.atherosclerosis.2014.05.962 PMID: 24956534
27. Kovacic JC1, Lee P, Baber U, Karajgikar R, Evrard SM, Moreno P, et al. (2012) Inverse relationship between body mass index and coronary arterycalcification in patients with clinicallysignificantcoronary-lesions. Atherosclerosis 221:176–182. https://doi.org/10.1016/j.atherosclerosis.2011.11.020 PMID: 22204865
28. Liu Hong, Lu Hong-Yun (2014) Nonalcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol 20:8407–8415. https://doi.org/10.3748/wjg.v20.i26.8407 PMID: 25024598
29. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745–750. PMID: 12198701
30. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern 132:112–117.
31. Oni ET, Kalathiya R, Aneni EC, Martin SS, Blaha MJ, Feldman T, et al. (2015) Relation of physical activity to prevalence of nonalcoholic fatty liver disease independent of cardiometabolic risk. Am J Cardiol 115:34–39. https://doi.org/10.1016/j.amjcard.2014.09.044 PMID: 25456868
32. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. (2011) Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 343:d6891. https://doi.org/10.1136/bmj.d6891 PMID: 22102439